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Abstract
Although lactic acidosis is a prominent feature of solid tumors, we still have limited understanding of the mechanisms by
which lactic acidosis influences metabolic phenotypes of cancer cells. We compared global transcriptional responses of
breast cancer cells in response to three distinct tumor microenvironmental stresses: lactic acidosis, glucose deprivation, and
hypoxia. We found that lactic acidosis and glucose deprivation trigger highly similar transcriptional responses, each
inducing features of starvation response. In contrast to their comparable effects on gene expression, lactic acidosis and
glucose deprivation have opposing effects on glucose uptake. This divergence of metabolic responses in the context of
highly similar transcriptional responses allows the identification of a small subset of genes that are regulated in opposite
directions by these two conditions. Among these selected genes, TXNIP and its paralogue ARRDC4 are both induced under
lactic acidosis and repressed with glucose deprivation. This induction of TXNIP under lactic acidosis is caused by the
activation of the glucose-sensing helix-loop-helix transcriptional complex MondoA:Mlx, which is usually triggered upon
glucose exposure. Therefore, the upregulation of TXNIP significantly contributes to inhibition of tumor glycolytic
phenotypes under lactic acidosis. Expression levels of TXNIP and ARRDC4 in human cancers are also highly correlated with
predicted lactic acidosis pathway activities and associated with favorable clinical outcomes. Lactic acidosis triggers features
of starvation response while activating the glucose-sensing MondoA-TXNIP pathways and contributing to the ‘‘anti-
Warburg’’ metabolic effects and anti-tumor properties of cancer cells. These results stem from integrative analysis of
transcriptome and metabolic response data under various tumor microenvironmental stresses and open new paths to
explore how these stresses influence phenotypic and metabolic adaptations in human cancers.
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Introduction
Human cancers are extremely heterogeneous due to multiple
mutations in oncogenes and tumor suppressor genes, a range of
inherited germline variations and varying degrees of microenvi-
ronmental stresses. These tumor microenvironmental stresses
include tumor hypoxia, accumulation of lactic acid (lactic acidosis)
and depletion of glucose, glutamine and other nutrients [1]. These
stresses are largely caused by a combination of poor tissue
perfusion, abnormal tumor vasculature, uncontrolled proliferation
and dysregulated energy metabolism of cancer cells during tumor
development and progression. Importantly, these microenviron-
mental stresses also directly modulate physiological and metabolic
phenotypes of cancer cells and ultimately affect the clinical
outcomes of patients. With major variations known to exist among
different tumors, advances in the pretreatment assessment of the
influences of these stresses will aid in improved selection of
appropriate therapeutic strategies for individual patients. These
stresses and their downstream effects are also the targets of cancer
therapeutics, including anti-angiogenesis and hyperthermia treat-
ments. It is therefore important to fully understand the impact and
mechanism of how these stresses affect various tumor and non-
tumor cells in human cancers.
It is well known that cells resort to glycolysis instead of oxidative
phosphorylation to utilize glucose as energy source during
hypoxia. In addition, cancer cells have a preferential use of
glycolysis pathways for energy generation even in the presence of
oxygen – so called ‘‘aerobic glycolysis’’ as first proposed by Dr.
Otto Warburg [2]. These factors all likely contribute to high
glucose flux and form the basis of using glucose analog
18F-FDG to
detect tumor cells. Such dysregulated metabolisms in cancer cells
also lead to the accumulation of the metabolic product of glycolysis
– lactic acids in solid tumors. Many measurements have been
performed to determine the level of tumor lactate and significant
variations were found, with the medium range of 7–10 mM/g and
up to 25.9 mM/g [3–5]. These studies show that high tumor
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and resistance to treatment [3–5]. How lactic acidosis affects
tumor and non-tumor cells in human cancers has been the focus of
many elegant studies as summarized in several reviews [6–8]. The
exposure of cultured cells to lactic acidosis in vitro has been shown
to trigger calcium signaling [9], induce angiogensis gene
expression (e.g. VEGF, IL8) [10–12], HIF-1a stabilization [13]
and cell death [14]. Recent genomic analyses identify the
transcriptional responses of different cell types to acidosis and
high lactate [15–17]. These in vitro studies have clearly shown the
significant impact of lactic acidosis on the gene expression and
phenotypes of cancer cells.
However, it is often challenging to relate the influences of these
microenvironmental stresses in vitro to the complex cancer
phenotypes in vivo. We have previously overcome this challenge
by defining ‘‘gene signatures’’ based on sets of genes whose
expression levels are altered by lactic acidosis in vitro as quantitative
‘‘common phenotypes’’, and projecting them to the in vivo
microarray expression data of patients’ tumors [18]. We have
used this approach to successfully investigate the pathways of
hypoxia [19], vascular injury [20] and lactic acidosis [18] in
human cancers. This reciprocal flow of information between the in
vitro and in vivo systems demonstrate that lactic acidosis triggers
significant metabolic reprogramming by forcing cells to rely more
on oxidative phosphorylation as an energy source with the
suppression of glycolytic phenotypes [18]. Therefore, cellular
metabolism is critical in determining the impact of lactic acidosis
to tumor phenotypes and clinical outcomes.
In the use of microarrays to connect cultured cells with human
cancers, primary epithelial cells are often used to provide the
common and shared responses to the defined perturbations due to
their intact genetic materials and signaling circuitry [18–22].
However, given our intention to relate gene signatures to human
cancers, it is probably more relevant to assess signatures in cancer
cells. Cancer cell lines are also often easier to be transfected, thus
allowing genetic manipulations for mechanistic studies. In this
study, we used breast cancer cell line, MCF-7, to conduct a
detailed temporal analysis of lactic acidosis response and compare
the transcriptomic and metabolic responses of cancer cells to
hypoxia, lactic acidosis and glucose deprivation in parallel to gain
a further understanding of the underlying molecular mechanisms.
One important goal in understanding the cellular responses to
tumor microenvironmental stresses is to identify the key
regulator(s) responsible for these observed gene expression
response since such understanding will lead to important insights
into the development and progression of human cancers. For
example, the identification of hypoxia-inducible transcription
factors (HIFs) as central regulators in the hypoxia response and
its regulation at the level of protein stability has become crucial in
our understanding of tumor hypoxia [23–26]. HIF-1a protein
stabilization can also be seen in the development of multiple
neoplasms in patients with von Hippel-Lindau disease [27] or
mutations in several enzymes of the tricarboxylic acid (TCA) cycle,
such as succinate dehydrogenase (SDH) and fumarate hydratase
(FH) [28–30]. The glucose deprivation is another feature of tumor
microenvironmental stress caused by the imbalance between
supply and consumption [31]. Glucose deprivation triggers
‘‘starvation-like’’ signaling through the activation of AMPK and
LKB-1, which in turn activates TSC1/TSC2 and inhibits central
energy sensor mTOR activities to inhibit ribosomal biogenesis,
translation activities and proliferation [32]. The mutations in
LKB-1 and TSCs in the glucose sensing pathway lead to cancer
development in the Peutz-Jeghers Cancer Syndrome [33] and
Tuberous Sclerosis [34,35], respectively. In contrast, very little is
known about the transcriptional regulation of the lactic acidosis
gene response program. To uncover the molecular mechanisms by
which tumor cells respond to their microenvironment, we
conducted a detailed temporal transcriptional analysis of the
MCF7 breast cancer cell line under lactic acidosis and compared
this response to those elicited by glucose deprivation and hypoxia.
We identified a novel growth suppressive pathway (MondoA-
TXNIP) that portends better prognosis in breast cancer and
contribute to the anti-Warburg effects of lactic acidosis.
Results
The temporal transcriptional responses of MCF-7 under
lactic acidosis
We examined the temporal gene expression patterns of a breast
cancer cell line MCF-7 exposed to lactic acidosis (25 mM lactic
acid with pH 6.7) at various time points during the first 24 hours.
Cells were first brought to replicative arrest by serum withdrawal
for 24 hours before exposure to either control or lactic acidosis
conditions composed of pH 6.7 and 25mM lactic acid in the
presence of high levels of glucose (4.5 g/L) in triplicate of different
time points at 1, 4, 12 and 24 hrs to characterize the temporal
changes of gene expression patterns. The RNA samples harvested
from these MCF-7 cells were interrogated with Affymetrix
GeneChip U133 plus 2.0 arrays (,54,000 probe sets on
,47,000 transcripts and variants) with results deposited in Gene
Expression Omnibus (GSE19123).
Gene expression profiles of all MCF-7 cells were normalized by
RMA, zero-transformed against the average expression levels of
the same probe sets of the time-matched control samples as
performed previously [19,20]. 1761 probes sets showing with at
least two fold changes in at least two samples were selected and
arranged by hierarchical clustering according to similarities in
expression patterns (Figure 1A). This analysis showed that lactic
acidosis induced a dramatic change in the gene expression with
significant temporal patterns (Figure 1A and 1B).
Among the genes induced in MCF-7 by lactic acidosis, we found
PLAU, major histocompatility complex (MHC) type I and CD44,
and REDD1 (Figure 1B), a p53 transcriptional target following
Author Summary
Solid tumors usually have many differences in their
chemical environments, such as low oxygen, depletion of
glucose, high acidity (low pH), and accumulation of lactate,
from normal tissues. These changes are usually called
tumor microenvironmental stresses. In this study, we have
used microarrays to compare the transcriptional response
and metabolic adaptation in response to these different
stresses seen in the tumor microenvironments. Through
these comparisons, we have found that lactic acidosis
triggers a starvation response, highly similar to glucose
deprivation, even in the presence of abundant nutrients
and oxygen. Even the cells seem to be starved; cells under
lactic acidosis have decreased glucose uptake. We found
this unexpected biological behavior was due to the
paradoxical induction of a glucose-sensing Mondo-TXNIP
pathway. The activation of this novel anti-tumor pathway
under lactic acidosis contributes to the anti-Warburg effect
and the restriction of cell growth in tumorigenesis by
limiting nutrient availability and its inactivation may be
required for tumor progression under these microenviron-
mental stresses.
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PLoS Genetics | www.plosgenetics.org 2 September 2010 | Volume 6 | Issue 9 | e1001093Figure 1. Overview of the time course of lactic acidosis response in MCF-7. (A) The gene expression response of MCF-7 is shown when
exposed to lactic acidosis conditions at indicated time points. 1761 probes sets were selected by the criteria of at least two observations with at least
two fold changes and arranged by hierarchical clustering. Clusters of genes induced by different time points and repressed by lactic acidosis are
marked and further expanded in (B), and (C) with the names of selected genes shown. (D) The prognostic significance of the lactic acidosis pathway
activity in MCF-7 at 12 and 24 hours were assessed in the Miller breast cancer expression dataset. The tumors, stratified by the imputed signature
scores associated with the LA response, were used to generate Kaplan-Meier survival curves linking clinical outcomes with the indicated responses.
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be induced by lactosis in cancer cells [37]. Tumor necrosis factor
(TNF), Fas and connective tissue growth factors (CTGF) were only
induced in earlier time points and returned to baseline in the later
time points (Figure 1B). Among clusters of genes repressed by
lactic acidosis in the later time points is a large group whose
expression is closely linked to cell proliferation (cyclin D, PCNA,
CCRK, E2F3, and E2F6) (Figure 1C). These lactic acidosis-
repressed genes may reflect a physiological alteration that halts cell
proliferation as the cells try to preserve energy consumption under
metabolic stress [31,32].
To define the lactic acidosis response in MCF-7 at a pathway
level, we performed Gene Set Enrichment Analysis (GSEA) [38] to
compare the pathway composition in the gene expression of all
control vs. lactic acidosis samples of MCF-7 cells. We found that
samples exposed to lactic acidosis were enriched in gene sets
representing nutrient deprivation [39], the treatment of histone
deacetylase inhibitor trichostatin A (TSA) in cancer cells, breast
cancer good prognosis [40] and exposure of DNA damaging agent
(bleomycin) (Table S1). The gene expression of MCF-7 which has
been exposed to lactic acidosis was depleted in gene sets
representing E2F1 target genes, DNA replication, breast cancer
poor prognosis [40], mitotic cycles and RNA processing (Table
S1).
We previously showed that the hypoxia and lactic acidosis
response signatures elicited in cultured primary non-cancerous
cells HMECs could provide a molecular gauge of hypoxia and
lactic acidosis response for cancerous human tissues in vivo, and
also predict clinical outcomes. To test robustness of this gene
signature approach based now on cancerous cells, the lactic
acidosis gene signatures generated in MCF-7 were projected to the
Miller breast cancer data to evaluate a tumor-specific numerical
score representing the predicted signature of lactic acidosis – i.e.,
quantifying lactic acidosis pathway activity across tumors [41]; see
Materials and Methods section below and the detailed statistical
supplemental materials from a previous study [18]. Statistical
survival analysis then indicates that patients with tumors showing
higher levels of lactic acidosis pathway activity – defined by
projected signatures of 12 and 24 hours exposure in MCF-7 – had
significantly better clinical outcomes (Figure 1D), consistent with
our previous studies using HMEC [18]. The lactic acidosis gene
signature at 12 hour time point had the most consistent prognostic
significance across different tumor datasets, including three other
breast cancer expression studies with different stages of diseases
(Figure S1). These datasets include a study of 286 lymph node
negative early breast cancers from NKI (Wang) [42], and two
studies of invasive breast carcinomas (Sotiriou, Pawitan) [43,44].
We also measured the reproducibility and consistency of the
predicted lactic acidosis pathway activities in each tumor using
gene signatures generated in both MCF-7 and HMECs. We found
that the two variants of the lactic acidosis signature resulted in
highly similar predicted lactic acidosis activity, evidenced by
strongly correlated signature scores in Miller and other tumor
datasets (Figure 1E and Figure S2). This result suggests that
although there are differences between the lactic acidosis responses
at the gene level, the pathway level predictions based on the gene
signatures are similar and reproducible in both normal primary
and breast cancer cells.
Lactic acidosis triggers ‘‘starvation’’ response
In the GSEA analysis for the MCF-7 cells exposed to lactic
acidosis, we found enrichment in the starvation pathways caused
by the deprivation of glucose and glutamine obtained in an
independent study [39]. Such association between lactic acidosis
and nutrient deprivation was consistent with the reduced ATP
production under lactic acidosis [18]. To test for such association,
we directly compared the gene expression of MCF-7 cells of lactic
acidosis with cellular starvation stress caused by glucose depriva-
tion. We performed parallel global transcriptional analysis on the
MCF7 cells in quintuplicate which had been exposed to lactic
acidosis and 1% oxygen (hypoxia) in the media with high glucose
(4.5g/L) and glucose deprivation (using media 0g/L glucose) for
4 hours. Similar parallel analysis was performed for subsets of
genes involved in metastasis and invasive capacity [45,46]. RNAs
from these MCF-7 cells were extracted and hybridized to
Affymetrix GeneChip U133 plus 2.0 arrays, normalized by
RMA and zero-transformed by deducting the mean expression
values for samples under control condition. 3903 probe sets were
selected by the criteria of at least two observations with at least two
fold changes and arranged by hierarchically clustering (Figure 2A
and 2B). Unexpectedly, we noted a highly similar transcriptional
response to lactic acidosis and glucose deprivation which is distinct
from the hypoxia response (Figure 2A). The similarity of the lactic
acidosis and glucose deprivation response was observed in both
induction and repression of a large number of common sets of
genes, including major histocompatility complex (MHC) type I &
II, DNA repair gene, alkB (alkyation repair homolog 7), and
CTGF, Jun and TNF (Figure 2B), which were also seen in our
previous time course experiment (Figure 1B). In contrast, hypoxia
elicited a very distinct transcriptional response with the upregula-
tion of many known hypoxia-inducible genes such as EGLN3,
CA9, stanniocalcin1 (STC1), BNIP3 and genes involved in
glycolysis, including pyruvate kinase (PKM2) (Figure 2B) [19]. In
a previous microarray study of the stress response in yeast
Saccharomyces cerevisiae, the induction of a share set of ‘‘common
stress genes’’ was a prominent feature [47]. In contrast, there was
only a small cluster of genes which were induced by lactic acidosis,
glucose deprivation and hypoxia, which may represent ‘‘common
stress genes’’ in MCF-7 cells (Figure 2B). These genes include
HIG-2 (hypoxia-inducible gene) and REDD, both genes reported
to be induced by hypoxia (Figure 2B).
Since glucose deprivation is known to trigger cellular starvation
response, this similarity in the transcriptional responses suggests
that lactic acidosis may also trigger a ‘‘starvation’’ response seen
for nutrient deprivation. To test this possibility, we measured the
effects of lactic acidosis on several biochemical markers of
starvation response in MCF-7 (Figure 2C). AMP-activated protein
kinase (AMPK) is a highly conserved energy-sensing heterotri-
meric complex that plays a key role in the regulation of energy
homeostasis; it becomes phosphorylated at Thr172 of AMPK a by
an elevated AMP/ATP ratio due to various stress indicating
energy stress and starvation. We find that lactic acidosis
significantly increased Thr172 phosphorylation of AMPK, even
in the presence of high levels of glucose and amino acids in the
media (Figure 2C). The Mammalian Target of Rapamcyin
(mTOR) is another crucial cellular sensor for energy status and
a crucial downstream target of AMPK [48,49]. We examined how
(E) Scatter plots showing the relationship between the estimated lactic acidosis pathway activities using the pathway signature obtained in HMEC (Y-
axis) vs. the signature obtained in MCF-7 (X-axis) at 12 and 24 hours. Each point in the scatter plot represents a single tumor from the indicated breast
cancer data set. The overall correlation (R) and statistical significance/p-value (p) between the lactic acidosis signature scores elicited in MCF-7 and
HMECs across all samples is shown the data set.
doi:10.1371/journal.pgen.1001093.g001
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PLoS Genetics | www.plosgenetics.org 4 September 2010 | Volume 6 | Issue 9 | e1001093Figure 2. The lactic acidosis triggers starvation response. (A) The transcriptional response of MCF-7 to the lactic acidosis, glucose deprivation
and hypoxia at four hours. Selected gene clusters which were induced commonly by lactic acidosis and glucose deprivation and hypoxia, by lactic
acidosis and glucose deprivation, or by hypoxia alone were highlighted and expanded in (B) with selected names shown. (C) Lactic acidosis triggers
the activation of AMPK (phosphorylation at Thr 172) and the inhibition of mTORC1 as manifested by the reduction of S6K phosphorylation at Thr 398.
doi:10.1371/journal.pgen.1001093.g002
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ylation of its downstream target S6 kinase (S6K) and found it
dramatically reduced the S6K phophorylation (Figure 2C). Taken
together, these data supported the notion that lactic acidosis
triggers a cellular starvation response similar to that of glucose
starvation, with AMPK activation and mTOR inhibition. These
biochemical changes are likely to contribute to reduced cell growth
and proliferation under lactic acidosis as evidenced by gene
expression (Figure 1C).
The distinct metabolic effects of lactic acidosis and
glucose deprivation
Knowing that lactic acidosis can inhibit tumor glycolysis [18],
we evaluated how lactic acidosis and glucose deprivation affect
glucose uptake using 2-deoxy-D-[2,6-
3H]-glucose. While glucose
deprivation increased the uptake of the glucose by 84%, lactic
acidosis significantly reduced the glucose uptake by 67%
(Figure 3A). The inhibition of glucose uptake by lactic acidosis
was consistent with the reduced glucose consumption and
decreased lactate production we have reported previously.
However, this result was not consistent with the expected
increased uptake of glucose to increase energy generation
associated with AMPK activation and cellular starvation, as seen
in glucose deprivation [50]. Therefore, in spite of the shared
AMPK activation, mTORC1 inhibition and similar transcription-
al responses, lactic acidosis and glucose starvation triggered
opposite effects on glucose uptake.
To identify transcriptionally regulated genes that may contrib-
ute to these opposite metabolic responses, we used the discordance
to select genes with significant but opposite expression changes
under lactic acidosis and glucose deprivation. This analysis
identified 115 probe sets (Table S2); 49 were induced by lactic
acidosis and repressed by glucose deprivation while 66 were
repressed by lactic acidosis and induced by glucose deprivation
(Figure 3B). The three probe sets with the largest induction levels
under lactic acidosis were all associated with thioredoxin
interacting protein (TXNIP or Vitamin D3-upregulated protein
1, VDUP1) (Figure 3B). TXNIP was strongly induced by lactic
acidosis, and suppressed by glucose deprivation. While hypoxia
was reported to trigger TXNIP expression [51], we only noted a
modest increase (,40%) in our experiment. We tested for the
prognostic significance of this differentially expressed signature by
projecting the 115 gene signature into the Miller breast tumor data
set. Due to different arrays used in that data set, this results in 109
of the 115 signature probes present in the Miller data set. We find
that higher levels of this signature also indicate favorable outcomes
(Figure S3A). The three TXNIP probe sets alone in fact have
prognostic significance comparable with that of the signature
(Figure S3B); on re-evaluating the signature after removal of these
three TXNIP probe sets, we find that the reduced signature
maintains prognostic significance albeit at a slightly reduced level
(Figure S3C).
When we examined expression of MCF-7 and HMEC under
lactic acidosis at different time points, we also noted significant
induction of TXNIP and its parralogue alpha-arrestin domain
containing 4 (ARRDC4) (Figure S4). Real-time RT-PCR further
confirmed the induction of TXNIP (up to 4–5 fold) and ARRDC4
transcripts (up to 3.4 fold) in MCF-7 (Figure 3C and Figure S5). In
addition, lactic acidosis also induced TXNIP expression in other
cancer cell lines, including WiDr (colon cancer cell) and SiHa
(cervical cancer cell) (Figure S6).
TXNIP expression is known to be induced by glucose exposure
[52,53]. Since there were high levels of glucose (4.5g/dL) in both
control and lactic acidosis media, we further clarified the role of
glucose vs. lactic acidosis in the TXNIP induction using real-time
PCR to determine the level of TXNIP in MCF-7 cultured under
different glucose and lactic acidosis conditions (Figure 3D).
Glucose (4.5g/dL) or lactic acidosis alone increased TXNIP levels
by approximately 4–5 fold (Figure 3D). In the presence of both
high glucose levels and lactic acidosis, TXNIP was induced up to
18 fold (Figure 3D). Thus lactic acidosis and glucose exposure are
both potent inducers of TXNIP with synergistic induction
potential, suggesting distinct mechanisms of TXNIP induction
by these two stimuli.
To define the individual contribution of lactosis vs. acidosis, we
tested the level of TXNIP induction under different degrees of
lactosis (12.5 or 25 mM lactate) and acidosis (pH 6.7) (Figure 3E
and 3F). We found that acidosis alone, but not lactosis alone, led to
the TXNIP induction, consistent with our previous study [18]
(Figure 3E). Although lactosis alone did not induce TXNIP, the
addition of lactate to the acidosis conditions led to a dose-
dependent augmentation of the TXNIP induction (Figure 3E).
Importantly, this effect on TXNIP induction was present even
under 10 or 12.5 mM lactate, a level seen in many human tumors
(Figure 3E and 3F). We also measured how lactosis and acidosis
affected glucose uptake, and found that acidosis, but not lactosis,
led to a reduction in glucose uptake, a pattern consistent with
TXNIP induction (Figure 3G).
Although TXNIP was initially identified as a protein interacting
with thioredoxin and modulating cellular responses to oxidative
stresses, it has the ability to inhibit glucose uptake and is being
recognized as an important regulator of dysregulated metabolism
in diabetes [54,55]. Therefore, the upregulation of TXNIP under
lactic acidosis make it an attractive candidate contributing to the
anti-Warburg effects and inhibition of tumor glycolysis under
lactic acidosis [18]. To investigate this, we silenced the TXNIP
transcripts with two independent siRNAs and confirmed the
successful reduction of the TXNIP protein (Figure 4A). Consistent
with the previously known role of TXNIP to inhibit glucose uptake
[55], the silencing of TXNIP by siRNAs led to significant decrease
in the reduction of glucose uptake under lactic acidosis culture
condition (Figure 4B). Lactic acidosis caused 52% repression of
glucose uptake in MCF7 cells transfected with non-targeting
siRNAs (-). In cells transfected with two different siTXNIPs (T1,
T2), glucose uptake was increased while the repressing effect of
lactic acidosis was decreased to 39% and 44% respectively
(Figure 4B). In addition, we found the silencing of TXNIP in
MCF-7 increased both the glucose consumption and lactate
productions under normal media, but lactic acidosis significantly
reduced both the glucose consumption and lactate production in
all treated cells (Figure S7).
Although the TXNIP gene silencing reduced the glycolysis
inhibition under lactic acidosis, the effects were modest, which
may be due to the remaining level of TXNIP. We further tested
the effect of TXNIP knocking out in the TXNIP deficient MEF
cells [56]. Lactic acidosis caused 68% reduction in glucose uptake
in the wild-type (WT) MEF cells. In contrasts, lactic acidosis only
reduced the glucose uptake by 28% in TXNIP knockout (TKO)
MEF cells (Figure 4C). To further test for the role of TXNIP
upregulation in the lactic acidosis response, we exposed the wild
type and TXNIP deficient MEF cells to the lactic acidosis
conditions (10 mM lactate, pH 6.7) and performed gene expres-
sion analysis using the Affymetrix mouse 430A2 GeneChip and
normalized the expression data by RMA. We first examined the
effects of the disruption of TXNIP on the gene expression of MEF
cells by performing zero transformation of TXNIP deficient
against the average expression in the wild type MEF cells (Figure
S8). We found 798 probe sets whose expression was altered at least
Lactic Acidosis Triggers TXNIP through MondoA
PLoS Genetics | www.plosgenetics.org 6 September 2010 | Volume 6 | Issue 9 | e1001093Figure 3. The induction of TXNIP under lactic acidosis. (A) The amount of glucose uptake of the MCF-7 under control, lactic acidosis and
glucose deprivation conditions. (B) Heat map shows expression of the 115 selected probe sets in MCF-7 placed in control, lactic acidosis, glucose
deprivation and hypoxia for four hours with the probe sets for TXNIP highlighted. (C) The level of TXNIP transcripts determined by real-time PCR in
the MCF-7 under indicated conditions. (D) The level of TXNIP transcripts determined by real-time PCR in the MCF-7 under the four indicated
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repressed in the TXNIP KO MEF cells were TXNIP, COX2,
collagens and many other genes in the HOX genes involved in
pattern specification (Figure S8). Among the induced in the
TXNIP KO MEF cells were genes in the complement activation,
AP2, and Notch3 (Figure S8).
To define the role of TXNIP in the lactic acidosis gene
expression, we compared the respective lactic acidosis response of
the wild type and TXNIP deficient MEF cells by zero-
transformation against the corresponding cells cultured in the
control conditions. 1327 probe sets showing with at least 1.7 fold
changes in at least two samples were selected and arranged by
hierarchical clustering according to similarities in expression
patterns (Figure 4D). This analysis showed that the loss of TXNIP
reduced the induction and repression of a significant number of
genes as shown in the three gene clusters (Figure 4D), including the
repression of many cell-cycle related genes under lactic acidosis. In
addition, the loss of TXNIP led to a statistically significant
reduction in the overall degrees of induction and repression
(p,0.0001) for the average expression of the 1049 repressed and
278 induced genes (Figure S9A and Figure 9B). We also tested the
ability of lactic acidosis to repress the proliferation of MEF cells
and found that the proliferation of the wild type, but not TXNIP
deficient MEF cells, were repressed by lactic acidosis (Figure 4E).
This observation is consistent with the reduced repression of cell
cycle genes under lactic acidosis seen for the TXNIP deficient
MEF cells (Figure 4D). Taken together, these data showed that
TXNIP induction contributes to the inhibition of glycolysis
phenotypes, metabolic reprogramming, and cell cycle arrest and
gene expression under lactic acidosis.
The role of the MondoA:Mlx complex in the activation of
TXNIP by lactic acidosis
Glucose-induced TXNIP transcription depends on a short
proximal region of the TXNIP promoter. Specifically, this region
includes a well conserved Carbohydrate Response Elements
(ChoRE) consisting of two E-boxes [53]. We first tested the
influence of lactic acidosis on the reporter constructs driven by the
promoters of TXNIP and ARRDC4 and found that lactic acidosis
could induce the reporter activities of both constructs by more
than 6 folds (Figure 5A). Importantly this induction of reporter
activity under lactic acidosis was reduced by 61% with mutation in
the ChoRE of the TXNIP promoter (Figure 5A), indicating the
importance of the ChoRE regions to the transcriptional activation
of TXNIP under lactic acidosis.
The transcriptional activation through two E-boxes in the
promoters of TXNIP upon glucose exposure has been reported to
be caused by the binding MondoA:Mlx [57] or Carbohydrate
Response Elements-binding protein (ChREBP) [58]. MondoA is
likely to be more relevant in the observed lactic acidosis response
of MCF-7 given its higher expression levels in MCF-7 and the
simultaneous upregulation of both TXNIP and ARRDC4 under
lactic acidosis [57]. MondoA:Mlx complexes are held latently at
the outer mitochondrial membrane (OMM), yet shuttle between
the OMM and the nucleus suggesting that they facilitate
communication between these two essential organelles. Mon-
doA:Mlx complexes are sensors of intracellular glucose concen-
tration and accumulate in the nucleus following increases in
glucose-6 phosphate to occupy the E-box-containing promoters of
targets such as TXNIP and ARRDC4 [57]. To directly test the
inducible physical binding of MondoA to the promoter regions of
TXNIP and ARRDC4 under lactic acidosis, chromatin-immuno-
precipitation (CHIP) was performed with the antibody against
MondoA in MCF-7 cells which have been exposed to lactic
acidosis conditions of different acidity. We detected increased
specific binding of MondoA to the promoter regions of TXNIP
and ARRDC4 with more acidic lactic acidosis environments
(Figure 5B). These results indicated that the MonoA became
activated to occupy the promoters of TXNIP and ARRDC4 under
lactic acidosis and these binding sites were important for their
transcriptional inductions.
To further determine the role of MondoA in the induction of
TXNIP under lactic acidosis, we used two different sets of siRNAs
to knock down MondoA by gene silencing (Figure 5C). During
lactic acidosis, the level of MondoA protein did not change, while
TXNIP was induced significantly (Figure 5C). This induction of
TXNIP was significantly reduced at both levels when MondoA
was reduced by both sets of siRNAs targeting MondoA (Figure 5C).
The silencing of MondoA also led to increased glucose uptake
under both control and lactic acidosis condition (Figure 5D), a
result similar to the silencing of TXNIP (Figure 3F and 3H). While
lactic acidosis caused 57% repression in MCF7 cells transfected
with non-targeting siRNA, such repression was reduced to 44%
and 40% with MCF7 cells transfected with two different siRNAs
targeting MondoA (M1 and M2). The degree of the lactic acidosis-
induced repression of the glucose uptake was lower after the
silencing of MondoA by two independent siRNAs (Figure S10).
Although gene silencing led to significant reduction of MondoA,
the remaining MondoA level may still account for the slight
induction of TXNIP under lactic acidosis. To further examine the
effects in the absence of MondoA, we tested the MondoA
knockout MEF (mouse embryonic fibroblasts) cells created by the
cre-loxP system (CWP and DEA, manuscript submitted). In the
complete absence of MondoA, both the basal and inducible level
of TXNIP under 2-DG or lactic acidosis was completed abolished
(Figure 5E). Importantly, the re-introduction of full length
MondoA back to the MEF cells fully restored the induction of
TXNIP under lactic acidosis (Figure 5E). Taken together, these
results demonstrate the critical role of MondoA in regulating
TXNIP under both glucose exposure and lactic acidosis.
TXNIP expression and lactic acidosis pathways in human
cancers
To determine the prognostic significance of TXNIP expression
in human cancers, we performed survival analyses using TXNIP
expression as the sole predictor of survival time. Breast cancers in
the Miller dataset stratified based on TXNIP expression were
found to have significant differences in clinical phenotypes; tumors
with high TXNIP have better survival and clinical outcomes
(Figure 6A, p=0.00115). Similar results were also obtained in the
three other breast cancer datasets. To test whether the in vitro
correlation of TXNIP induction with lactic acidosis pathway
activity persists in vivo, we compared the predicted lactic acidosis
pathway activity with the TXNIP expression levels in the breast
cancer data sets and found a positive correlation in all four data
sets; although the relationship is of limited predictive value with
low R values reflecting a noisy relationship, the positive
relationship is statistically significant and consistent across tumor
conditions for lactic acidosis and glucose level. (E, F) The level of TXNIP determined by real-time PCR (E) and Western blot (F) in the MCF-7 under five
indicated conditions with or without acidity (pH 6.7) and carrying levels of lactate (10, 12.5 or 25 mM). (G) The amount of glucose uptake of the MCF-
7 under control, acidosis, lactosis (25mM) and lactic acidosis (25mM) conditions.
doi:10.1371/journal.pgen.1001093.g003
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PLoS Genetics | www.plosgenetics.org 8 September 2010 | Volume 6 | Issue 9 | e1001093Figure 4. Identification of TXNIP as a regulator of lactic acidosis response. (A) The level of TXNIP proteins treated with control or siRNAs
against TXNIP under control or lactic acidosis conditions. (B) The level of glucose uptake in the MCF-7 treated with the indicated conditions. Lactic
acidosis caused 52% repression of glucose uptake in MCF7 cells transfected with non-targeting siRNAs (-) as negative control. In cells transfected with
two different siTXNIPs (T1, T2), glucose uptake was increased and the repressing effect of lactic acidosis was decreased to 39% and 44% respectively.
(C) Lactic acidosis caused 68% repression in wild-type (WT) MEF cells but only 28% repression in TXNIP knockout (TKO) MEF cells. (D) The gene
expression response of wild type and TXNIP deficient MEF cells was shown when exposed to 10mM lactic acidosis conditions. 1327 probes sets
showing with at least 1.7 fold changes in at least two samples were selected and arranged by hierarchical clustering according to similarities in
expression patterns. Clusters of genes whose induction and repression was most affected by TXNIP are marked and further expanded with the names
of selected genes shown. (E) The effect of the control and lactic acidosis (10mM LA and 25mM LA) on the cell growth in percentage of the wild type
and TXNIP deficient MEF cells.
doi:10.1371/journal.pgen.1001093.g004
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another paralouge of TXNIP and downstream target of MondoA.
When breast cancers were stratified by the level of ARRDC4,
tumors with higher levels of ARRDC4 had better prognosis and
clinical outcome in the both breast cancer data (Miller and
Pawitan) in which ARRDC4 was measured (Figure 6C). The
expression of ARRDC4 was also positively associated with the
predicted lactic acidosis pathway activity in these two breast
cancer datasets (Figure 6D). These observations demonstrate the
high degree of in vivo correlation between the expression of TXNIP
and ARRDC4 and the lactic acidosis pathway activity in human
cancers. It is also consistent with the known role of TXNIP as a
probable tumor suppressor in several cancer types where it has
been shown to suppress oncogenic phenotypes and its loss of
function linked with cancer development [59–61]. Therefore, the
expression of both TXNIP and ARRDC4 are potentially
important mediators of the lactic acidosis response and suggest
the important prognostic significance of molecular pathways
driven by Mondo-Mlx in human cancers.
Discussion
Hypoxia, glucose deprivation and lactic acidosis are all well-
recognized tumor microenvironmental stresses. Each of these
stresses has distinct features – either limited availability of energy
fuel (glucose), depletion of cofactor (oxygen) or accumulation of
metabolic byproducts (lactic acidosis). Previous studies in various
settings have shown that glucose deprivation causes metabolic
stress and induces adaptive responses —so-called ‘‘starvation
response’’ – manifest by AMPK activation, mTOR inhibition and
multiple other biochemical and metabolic changes in cancer cells.
Tumor hypoxia has also been reported to induce such metabolic
stresses [62]. Here, we have shown that lactic acidosis triggers a
‘‘starvation’’ response similar to glucose deprivation as evidenced
by the biochemical and transcriptional responses. Since this occurs
even in the presence of abundant oxygen and nutrients, this
response may represent ‘‘pseudo-starvation’’. This is especially
unexpected given the presence of high levels of lactate as an
additional potential energy source for cancer cells [63].
Adaptive changes during the starvation response often reflect a
need to preserve energy homeostasis during energy depletion by
switching off cell growth and proliferation and many anabolic
processes, such as protein, carbohydrate and lipid biosynthesis. In
addition, there is also a simultaneous increase in cellular
catabolism and breakdown of various energy sources to increase
energy production. Even with this shared energy need, different
tumor microenvironmental stresses employ different means to
accomplish such adaptations to preserve energy homesostasis.
During hypoxia, the essential cofactor (oxygen) required for
oxidative phosphorylation becomes limited. As a result, the
transcriptional factor HIF-1a activates genes encoding glucose
transporters and enzymes involved in the glycolytic process shift to
the use of glycolysis as the main source of energy generation. In
the setting of glucose deprivation, there is a lack of fuel required
for glycolysis as energy source. During these energy shortages,
AMPK become activated to modify many proteins controlling
energy flow to increase the energy generation in mitochondria
from other source of fuels, such as oxidative of fatty acid and
amino acids [64]. In addition, the inhibition of mTOR turns off
many energy-consumption processes (e.g., translation, cell growth
and proliferations) in an effort to restore energy homeostasis. The
lactic acidosis-induced cell cycle arrest may be caused by many
changes, including the induction of AMPK, mTOR inhibition,
TXNIP and cell cycle arrest caused by the induction p57, p21 and
other inhibitors of cellular proliferation. Moreover, the expression
of many genes involved in glycolysis is affected by changes in
histone acetylation of chromatin [65]. These responses triggered
by glucose deprivation may be also important for energy
maintenance and survival in acidosis-induced apoptosis [66,67].
For example, AMPK may help in re-directing cells to utilize non-
glucose energy sources (e.g., fatty acids and amino acids) and
increased mitochondria activities under lactic acidosis [18,68]. In
addition, since the AMPK activator AICAR reduces the
expression of lactate importer monocarboxylate transporter
(MCT)-1 but increases the expression of the lactate exporter in
MCT4 [69], AMPK activation under lactic acidosis may also
inhibit the uptake of excessive cellular lactate. These stress
environments are also likely to select for tumor cells that have
developed strategies to survive energy deprivation with better
energetic balance. The genetic mutations of many genes involved
in these processes of adaptation to hypoxia and glucose
deprivation are known to associate with tumor development.
These findings highlight the crucial role of biochemical, metabolic
control of energy homeostasis in tumor development.
There are many possible explanations as to how lactic acidosis
leads to AMPK activation, mTOR inhibition and other features of
the starvation response. For example, lactic acidosis can reduce
ATP generation in cells [18] and thus lead to a high AMP/ATP
ratio to activate the AMPK. Extracellular acidosis also triggers an
increase in cytosolic Ca
++ [9] which may activate CaMKK – an
alternative AMPK upstream kinase [70–72] – to phophorylate and
activate AMPK. Lactic acidosis may also cause intracellular
nutrient depletion with reduced uptake of glucose (this study) and
glutamine through the inhibition of acidosis-sensitive glutamine
pumps [73,74]. This depletion of intracellular pools of nutrients
may in turn repress the energy sensor mTOR, the translation
activities and ribosomal biogenesis required for cellular prolifer-
ation. In the future, it will be important to further dissect the
contribution of each factor and signaling components to the
induction of these starvation responses under lactic acidosis to
further our detailed understanding of their impact on the
metabolisms and phenotypes of cancer cells.
In both hypoxia and glucose deprivation, there is an increase in
glucose uptake and glycolysis to provide essential fuel through
induction (by HIFs), modification of glucose transporters (by
AMPK) [75,76] and histone acetylation via ATP-citrate lyase [65].
In contrast, lactic acidosis presents a different instance of
starvation with inhibition of glucose uptake and other glycolysis
Figure 5. MondoA is responsible for the TXNIP induction under lactic acidosis. (A) The fold of induction of normalized luciferase activities
under lactic acidosis for the indicated reporter constructs driven by wild type TXNIP promoter, TXNIP promoter with the ChoRE mutated and ARRDC4
promoters. (B) The physical binding of MondoA to the promoters of TXNIP and ARRDC4 was assessed by Chromatin-Immunoprecipitation for MCF-7
cells under lactic acidosis with different indicated pH. (C) The level of MondoA and TXNIP proteins in MCF-7 cells treated with control or two siRNAs
against MondoA under control or lactic acidosis conditions. (D) The level of glucose uptake in the MCF-7 treated with the indicated conditions. Lactic
acidosis caused 57% repression in MCF7 cells transfected with non-targeting siRNA (-). The repression effect of lactic acidosis was decreased to 44%
and 40% with MCF7 cells transfected with two different MondoA siRNAs (M1 and M2). (E) The level of MondoA and TXNIP proteins shown by Western
in the indicated mouse embryonic fibroblasts (MEF): lox/lox (MEF with wild type MondoA), 2/2 (lox/lox MEF with cre overexpression to delete
MondoA) and 2/2+MondoA FL=2/2 reconstituted with FL human MondoA under control, 2-DG, pH 7 and lactic acidosis conditions.
doi:10.1371/journal.pgen.1001093.g005
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PLoS Genetics | www.plosgenetics.org 11 September 2010 | Volume 6 | Issue 9 | e1001093Figure 6. The expression of TXNIP, ARRDC4, and lactic acidosis pathways in human cancers. (A,C) The tumors in the indicated dataset
stratified by the expression of TXNIP (A) and ARRDC4 (B) were used to generate Kaplan-Meier survival curves for linking clinical outcomes with the
TXNIP expression levels. (B,D) Scatter plots showing the relationship between the expression of TXNIP (B) or ARRDC4 (D) (Y-axis) and predicted lactic
acidosis pathway activities based on the MCF-7 12 hour lactic acidosis gene signatures (X-axis) in the indicated tumor datasets. Each point in the
scatter plots represents a single tumor from the indicated breast cancer data sets. The overall correlation (R) and statistical significance/p-value (p)
across all samples is shown.
doi:10.1371/journal.pgen.1001093.g006
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also dissected two distinct molecular pathways (AMPK-mTORC1,
MondoA-TXNIP) by which various microenvironmental stresses
influence cancer metabolic phenotypes. While the AMPK-mTOR
response is similar under lactic acidosis and glucose deprivation,
the MondoA-TXNIP is affected in opposite directions by these
two stresses. Given the continuous need for energy generation with
reduced ATP and metabolic substrate from the glycolysis
pathways under lactic acidosis, cells are likely to undergo extensive
metabolic reprogramming to utilize other nutrients as energy
sources. This idea is supported by the increased reliance on
mitochondria for ATP generation. Our analysis has highlighted
the potential roles of TXNIP and AMPK in this metabolic
reprogramming. The induction of TXNIP under lactic acidosis
and its ability to inhibit glucose uptake and reduce lactic acidosis
production from glycolysis form a negative feedback loop. In
addition, the loss of TXNIP leads to many features of Warburg
effects and glycolytic phenotypes of cancer cells, opposite to the
influences of lactic acidosis [18]. High TXNIP expression is
associated with favorable outcomes, consistent with its postulated
role as a tumor suppressor gene based on its growth-suppressing
activity and the increased occurrences of tumors with deficiency of
TXNIP [59,60,78,79]. These findings may provide important
insights into the regulatory mechanisms of TXNIP as well as the
phenotypic alterations under lactic acidosis. TXNIP may affect the
glucose uptake through the suppression of two important
regulators of glycolysis, Akt [56] and HIF-1a [80]. In addition,
TXNIP is known for other properties, which may explain its effect
on the gene expression during lactic acidosis. TXNIP is a negative
regulator of cellular oxidative tolerance by binding thioredoxin
[81–83] and as a feedback regulator of S-nitrosylation [84]
relevant in the cellular adaptive response to tumor microenviron-
mental stresses. For example, repression of TXNIP enhancing the
anti-oxidative capacity during glucose deprivation may be
required to cope with increased mitochondria oxidative stresses
[85]. 2-Deoxy-D-glucose (2-DG) can enhance the cytotoxicity of
cisplatin through mechanisms involving increased oxidative stress
[86]. Since 2-DG is a strong inducer of TXNIP [57], a lower anti-
oxidative capacity caused by 2-DG exposure may also involve
neutralization of the anti-oxidative capacity of thioredoxin by
TXNIP induction.
TXNIP and ARRDC4 are both transcriptionally regulated by
the MondoA:Mlx complex to coordinate the fuel status of cellular
metabolism and proliferation [57,87]. Our findings identify lactic
acidosis as a novel stimulus for the activation of MondoA and
induction of TXNIP/ARRDC4. Even though we have identified
the importance of MondoA-TXNIP of one component of the
lactic acidosis response, there are still many aspects of lactic
acidosis which remained unexplained, such as similarities to the
glucose deprivation response. At least two factors are likely to be
relevant for the shared gene expression response of glucose
deprivation and lactic acidosis. First, these changes may lead to
significant changes in the level of acetyl-CoA, which in turn
impacts on histone acetylation of the chromatin of many target
genes [65]. In addition, AMPK activation under both stresses may
also impact on several transcription factors and co-activators to
affect gene expression [88,89]. It is likely that the anti-tumor
activities of AMPK activators (e.g., metformin or AICAR) [90–93]
may involve similar pathways triggered by lactic acidosis.
Many studies on the lactate levels in human cancers have found
that tumors with high lactate levels are associated with poorer
clinical outcomes, tumor aggression and treatment failure [3–5].
How do our finding of the association of the lactic acidosis
response with favorable outcomes reconcile with these studies?
There are at least four different ways how our results can be
reconciled with the clinical observation. First, our studies mainly
focus on the cellular response of cancer cells to short term
exposure of lactic acidosis. This result may be different from the
long term selection in the high lactic acidosis environments of
human tumors. For example, glucose deprivation triggers
starvation response with AMPK activation, mTOR inhibition
and cell cycle arrest during short term exposure [48]. During the
long term exposure to these stresses in human cancers, these
undesirable conditions may select for tumor cells with the somatic
mutations (such as K-Ras mutation [94]) that confers ability to
adapt these stress conditions and strong metastasis potential.
Similar selection pressure has also been suggested for the lactic
acidosis [1,15,95]. In addition, the high level of lactate in the
tumors is the downstream effects of the preferential use of
glycolysis pathways due to tumor hypoxia, which may lead to
more aggressive tumor behaviors and worse clinical outcomes.
While lactic acidosis itself may exert some anti-tumor influences,
this may not be enough to counter the influence of these somatic
mutations and hypoxia in driving the tumor aggressiveness. It is
also important to point out that the experimental evidence suggests
that the lactic acidosis response is mainly due to acidosis instead of
lactosis. Although we have found that lactosis may further
augment the acidosis response, lactosis by itself have relatively
little effects on the gene expression. Although the degree of the
cellular response to these stresses (such as CA9) can reflect the
levels of stresses (low tumor pO2) and serve as ‘‘endogenous
markers’’ of such stresses in human cancers, such connection are
not absolute and direct [96]. Therefore, the degree of lactic
acidosis response in human cancers may or may not correlate
directly with the tumor lactate levels.
Through the dissection of individual stresses in vitro, we have
shown here that lactic acidosis simultaneously triggers two anti-
tumor pathways (AMPK-mTOR and MondoA-TXNIP). There-
fore, triggering such responses in cancer cells using small molecule
compounds may have therapeutic potentials. It is of interest to
investigate the mechanisms by which the lactic acidosis response is
sensed and triggered in cancer cells. Extracellular lactate enters the
cells through the lactate transporter proteins of monocarboxylate
transporter (MCT), which may be also important for the lactic
acidosis response. Lactate has also been recognized for its role as
an energy source [63] and a signaling molecule to affect tumor cell
phenotypes and target of cancer therapeutics [97]. Previous studies
have shown that lowering the extracellular pH from 7.4 to ,6.7
will lead to a slight lowering of intracellular pH (pHi) from 7.4 to
6.9–7.0 [98,99]. Since many surface or cytosolic molecules exhibit
high sensitivity to pH, this drop in pHe and the corresponding
slight decrease in pHi may induce conformational changes to
trigger signaling events [100,101]. For example, it has been
postulated that inhibition of the acidosis-sensing glutamine pumps
leads to amino acid depletion [73,74] and increases in the
proteosome activity [102] in muscle cells, also contributing to
muscle loss during metabolic acidosis. Low pHi has also been
shown to directly enhance both DNA-binding and the TBP-
interacting capacity of the transcriptional factor Sp1 [103].
Similarly, it is possible that this slight drop in pHi may destabilize
the hydrogen bonds in several histone residues in the basic regions
of MondoA to causes its transcriptional activation of target genes
[57]. Homeostasis of pHi is mainly regulated by the sodium/
hydrogen exchanger (NHE) family of proteins [104,105] and such
regulation is dysregulated in cancer cells [106]. TXNIP is known
to be transcriptionally regulated by a variety of stresses and stimuli
[84,87,107] and it is possible that some of these stimuli may act
through modulating pHi to affect MondoA. TXNIP has been
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the growth-inhibiting TXNIP expression under alkaline pHi may
help to explain its permissiveness for cellular proliferation in
response to growth factors [108,109]. In addition, evidence is
accumulating for the role of membrane acid-sensing receptors in
either GPR4 family of G-protein coupled receptors (GPCR) and
Acid-Sensing Ion Channels (ASICs) in many cell types. These
acid-sensing receptors may also be critical in the observed response
in both the AMPK-mTOR and MondoA-TXNIP under lactic
acidosis. Importantly, these acid-sensing receptors can be
modulated by small compounds pharmacologically [110,111]
and thus have potential as cancer therapeutics [112,113]. For
instance, several glycolipids are known natural ligands of these
acid-sensing GPCRs and can activate or inhibit receptor responses
to acidosis. Small compounds blocking the ASICs have been used
to improve the symptoms and severity of stroke after vascular
blockage [114]. Similarly, the use of compounds modulating the
lactic acidosis response may mimic the tumor suppressor activities
of lactic acidosis in novel cancer therapeutics. The definition of key
genes and pathways will allow the use of genetic and chemical
means to identify how to modulate cellular lactic acidosis for
therapeutic purposes and thus potentially improve outcomes for
cancer patients.
Materials and Methods
Cell culture and conditions modeling different tumor
microenvironmental stresses
MCF7 breast cancer cell lines were cultured in DMEM
(GIBCO11995) with 4.5 g/L glucose, supplemented with 10%
fetal bovine serum, 16 non-essential amino acid and 16
antibiotics (penicillin, 10000UI/ml; streptomycin, 10000UI/ml).
MEF cells were cultured in DMEM media supplemented with
15% FBS. Lactic acidosis conditions were created with the
addition of 25mM or 10mM lactic acid (Sigma) to respective
media and adjusted to the desired pHs with HCL or NaOH.
Glucose deprivation was created by using 0 glucose/L media
(GIBCO11966). Hypoxia was created by lowering the oxygen
level to 1% oxygen. To stabilize the pH of DMEM media better,
25mM HEPES was also added into the media.
RNA isolation and microarray analysis
RNAs from MCF7 cells exposed to control or lactic acidosis
culture conditions for 1, 4, 12, 24 hr were collected at respective
time points and extracted with miRVana kits (Ambion), followed
by hybridization to Affymetrix Hu133 plus2 gene chips with
standard protocols. RNAs from MCF7 cells exposed to lactic
acidosis, glucose deprivation and hypoxia were extracted after
4 hour exposure with miRVana kits (Ambion) and hybridized to
Affymetrix Hu133 plus2 gene chips in a similar fashion. CEL files
were normalized by RMA using Expression console (Affymetrix),
filtered by indicated criteria, clustered with cluster 3.0, and
displayed with treeview. All the microarray results have been
submitted into GEO with accession number GSE19123. The
RNA from the treated MEF cells were interrogated by
hybridization to Affymetrix mouse 430A2 GeneChip with
standard protocols and processed in a similar fashion.
Statistical analyses
Gene expression signatures associated with 1,4,12, and 24 hour
lactic acidosis treatments were derived from RMA expression
values using standard Bayesian sparse multivariate regression
techniques, full details of which appear in previous publications
[18,115–117] For each treatment group (i.e. 1-,4-,12-, and 24-hr
lactic acidosis treatment), this estimated the probability of
differential expression for each Affymetrix probe as well as the
fold change of the differentially expressed transcripts, as compared
to the control. These values define the in-vitro signature of the
treatment. Projection of these signatures into the primary tumor
data sets is derived from the weighted inner product of the vector
of tumor gene expression values and the vector of regression
coefficients associated with the signature, as described in [117]: the






yg, where pg,k is the estimated probability
of differential expression of probe g in treatment k, bg,k is the estimated
fold change of the transcript, yg is the estimated residual variance of
probeg, andxg,i isthe RMA normalized expression value of probe g in
sample i. The signature score thus provides a relative measure of the
extent to which the pattern of expression described by the signature is
present or reversed in a given vector of expression values.
P-values associated with the significance of Kaplan Meier curves
were derived from survival analyses conducted using a Cox
proportional hazards model in MATLAB. Kaplan Meier curves
show the optimal stratification of high-risk and low-risk groups as
determined by choosing the partition threshold that maximizes the
area between curves. Measures of correlation and the associated P-
values for the signature score scatter plots were calculated using
the Pearson coefficient.
Full details of statistical analysis, including data and computer
code to replicate the analyses, are available as Dataset S1.
Realtime RT–PCR
RNAs were reverse-transcribed to cDNAs with SuperScript II
reverse transcription kit following the manufacturer’s protocol
(Invitrogen). cDNAs were then used as the substrate for gene
expression level measured by qPCR with Power SYBRGreen PCR
Mix (Applied Biosystem) and primers specific for TXNIP
(Forward: CTGGCGTAAGCTTTTCAAGG, Reverse: AGTG-
CACAAAGGGGAAACAC), ARRDC4 (Forward: CCCCCT-
CCCACATGGTCACA, Reverse: TCCCTGGCTCCCTTCC-
ATGTGT), Actin-beta (Forward: CTCTTCCAGCCTTCCTT-
CCT, Reverse: AGCACTGTGTTGGCGTACAG) following the
manufacturer’s protocol.
Glucose uptake assays
MCF7 cells were plated in 6-well/12-well plates at the density of
800,000/200,000cells per well. Once cells were more than 75%
confluent, they were washed with 16 PBS twice, followed by
application of serum starvation media (0.1%FBS) for three hours.
Cells were then treated with respective conditions for the desired
time. For MEF cells, they were plated in 12-well plates at the
density of 100,000 cells per well. Once they reached more than
70% confluence, applying respective indicated conditions for four
hours. For glucose uptake measurement, cells would then be
washed with 37uC KRH buffer twice, followed by adding in
500ul/200ul KRH buffer containing 0.5uCi/0.2uCi 2-deoxy-D-
glucose (GE Healthcare) for one hour in 37uC incubator. 20uM
cytochalasin B was added for negative controls. After incubation,
cells would be washed three times with 1ml/400ul of ice-cold
KRH buffer containing 20mM glucose and 0.5mM phloretin
to quench the glucose uptake. Finally, cells were lysed with
1ml/400ul RIPA buffer and the lysates were subjected to liquid
scintillation counting. Protein concentrations were measured with
Bradford assay. To measure the glucose uptake of genetically-
manipulated cells, glucose uptake was measured 24 or 48 hours
after the transfections.
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MCF7 cells were plated in 12-well plates for the density of
200,000 cells per well. Once the cells reached 60% confluence,
100nM siRNAs were transfected by using lipofectamine. To verify
the successful knocking down of the intended transcripts, RNAs
were collected with miRVana kit 24 hours after the transfection,
whereas 48 hours after the transfection, proteins were collected by
lysing the cells with RIPA buffer.
Western blot analysis
Proteins were collected with RIPA buffer and their concentra-
tions were measured with Bradford assay. Equal amounts of
proteins were loaded for the protein analyses. Primary antibodies
of AMPK, S6K (cell signaling), TXNIP (MBL) and anti-MondoA
antibodies were applied following the manufacturers’ protocols or
as described previously [57].
Cell proliferation assay
Wild type mouse embryo fibroblast (MEF) and TXNIP null MEF
cells were plated at the density of 25,000 cells per ml. The multi-
channel pipette was used to plate 100ul of cell suspension evenly into
the 96-well cell culture plate. Respective conditions of 10mM or
25mM lactic acidosis were applied the next day and cell number was
estimation by using a standard MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium)
colorimetric assay (Promega) 48 hours after respective treatments.
Chromatin Immunoprecipitation
ChIP studies were performed as described previously [57] using
an off-target region located on chromosome 10 to calculate fold
enrichment. Primer sequences for the promoters of TXNIP,
ARRDC4, and the off target control of the CHIP analysis are
available upon request to D.E.A.
Glucose and lactate measurement in media
MCF cells were plated in six-well plates at a density of 500,000
cells per well. The next day, non-targeting siRNAs and siRNAs
against TXNIP were transfected as described previously. After
24 hours, fresh media for the respective conditions, including
control and 25mM lactic acidosis were applied to cells for 48 hrs
when media were collected for glucose (ACCU-CHECK Aviva,
Roche) and lactate (ARKRAY) measurements with respective
meters. The results were normalized by cell numbers to obtain the
glucose consumption and the lactate production amount per
million cells.
Supporting Information
Dataset S1 Statistical code and other supporting material
contains data, code, and information on the statistical analysis of
in vitro expression data to generate signatures, as well as of in vivo
projection of signatures into the sets of human breast cancer data.
Analysis uses the BFRM software previously described and used in
multiple related studies [115] and freely available, with tutorial
examples. Supplementary material contains a readme describing
the setup and running of the analyses.
Found at: doi:10.1371/journal.pgen.1001093.s001 (0.03 MB ZIP)
Figure S1 The prognostic values of gene signatures reflecting
lactic acidosis response at different time points among the patients
in different cancer expression datasets. The graphs show Kaplan-
Meier curves for two patient subsets stratified by the level of lactic
acidosis response. The p-values are for regression coefficients of
the signature in the survival model analysis.
Found at: doi:10.1371/journal.pgen.1001093.s002 (0.27 MB PDF)
Figure S2 Scatter plots showing the relationship between the
levels of lactic acidosis response as defined by HMEC (24hrs) (Y-
axis) and MCF-7 at different time points of lactic acidosis exposure
(X-axis). Each point in the scatter plots represents a single tumor
from the indicated breast cancer data sets. The overall correlation
(R) and statistical significance/p-value (p) between the predicted
lactic acidosis pathway activities using these two breast cancer cells
across all samples is shown for the indicated data set.
Found at: doi:10.1371/journal.pgen.1001093.s003 (0.55 MB PDF)
Figure S3 The prognostic significance of the 109 genes (assayed
in the Miller datasets out of the 115 genes) which are affected in
opposite directions by lactic acidosis and glucose deprivation (LA/
GD). (B) The prognostic significance of three TXNIP probsets in
the Miller datasets. (C) The prognostic significance of the signature
of the 106 genes after the removal of the three TXNIP probesets in
the Miller dataset.
Found at: doi:10.1371/journal.pgen.1001093.s004 (5.02 MB EPS)
Figure S4 Heatmap showing the upregulation of TXNIP and
ARRDC4 in MCF-7 and HMECs at different time points of
exposure to lactic acidosis from the microarray analysis.
Found at: doi:10.1371/journal.pgen.1001093.s005 (0.21 MB PDF)
Figure S5 Realtime RT-PCR results of ARRDC4 expression
normalized by b-actin under control, lactic acidosis, glucose
deprivation, and hypoxia.
Found at: doi:10.1371/journal.pgen.1001093.s006 (0.24 MB PDF)
Figure S6 The induction of TXNIP in WiDr and SiHa cells
under lactic acidosis.
Found at: doi:10.1371/journal.pgen.1001093.s007 (0.28 MB PDF)
Figure S7 The measured glucose consumption (A) and lactate
production (B) of the MCF-7 which has been transfected with
indicated siRNAs either non-targeting (-) and TXNIP (T) under
control and lactic acidosis conditions.
Found at: doi:10.1371/journal.pgen.1001093.s008 (0.31 MB PDF)
Figure S8 The effect of TXNIP disruption on the gene
expression under control and 10mM lactic acidosis conditions.
798 probes sets showing with at least 1.7-fold changes in at least
two samples were selected and arranged by hierarchical clustering
according to similarities in expression patterns with the names of
selected genes shown.
Found at: doi:10.1371/journal.pgen.1001093.s009 (0.29 MB PDF)
Figure S9 The pair-wise t-test and p value for the comparison of
the 1048 repressed genes (A) and 277 induced genes (B) between
the TXNIP deficient and wild-type littermate MEF cells based on
the lactic acidosis gene expression derived by zero-transformation.
Found at: doi:10.1371/journal.pgen.1001093.s010 (0.62 MB PDF)
Figure S10 The amount (%) of lactic acidosis-induced repres-
sion in glucose uptake of the MCF-7 which has been transfected
with indicated siRNAs either non-targeting (-), MondoA (M1,
M2).
Found at: doi:10.1371/journal.pgen.1001093.s011 (0.22 MB PDF)
Table S1 The pathway composition analyzed by GSEA in the
MCF-7 exposed to lactic acidosis versus normal conditions for
samples in all time points.
Found at: doi:10.1371/journal.pgen.1001093.s012 (0.02 MB
XLS)
Table S2 The probesets and average folds of change in affected
by indicated conditions are shown for the 115 probe sets which
Lactic Acidosis Triggers TXNIP through MondoA
PLoS Genetics | www.plosgenetics.org 15 September 2010 | Volume 6 | Issue 9 | e1001093were affected in opposite direction by lactic acidosis and glucose
deprivation with the top 1% probability.
Found at: doi:10.1371/journal.pgen.1001093.s013 (0.01 MB
XLSX)
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